HyClone Laboratories, Inc. - - BioPharm International

ADVERTISEMENT

HyClone Laboratories, Inc.

BioPharm International
Volume 18, Issue 12

General Description



HyClone is a business unit within the Fisher Biosciences group, offering leading cell-culture products and bioprocessing systems for life-sciences research and protein-based drug production. Widely known as the premier brand of quality sera for cell culture, HyClone is also a leading brand of classical media, serum-free and protein-free media, process liquids and flexible, single-use BioProcess Container (BPC) systems, which are sterile, disposable bags specifically designed for transporting, mixing, dispensing, and storing sterile liquids and powders.

Chief Biopharmaceutical Techniques Supported

  • Cell Culture
  • Chromatography (elution buffers, buffer feed bags, collection bags)
  • Bioreactors
  • Media and buffer mixing
  • Vaccine production
  • Virus production
  • MAb production
  • Protein production

Facilities



HyClone's 31,000 ft.2 BioProcess Container (BPC) manufacturing complex located in Logan, UT has been designed and built in accordance with the needs and requirements of today's biopharmaceutical customer. This state of the art facility is ISO 9001:2000 certified and manufactures BPCs according to cGMPs. Other chief manufacturing locations include Novato, CA, and Cramlington, UK.

Major Products and Services

HyClone BioProcess Container (BPC) systems are single-use, disposable flexible containers (bags) for liquid handling. Manufactured of medical-grade plastics (passes USP Class VI medical-grade testing) and configured with ports, tubing, fittings and end treatments, BPC systems provide efficient means for sterile liquid handling in research and production settings.

Markets Served



HyClone serves the life sciences research market and the biopharm production/bioprocessing market, as well as some segments of the diagnostic, pharmaceutical, and clinical markets.

HYCLONE LABORATORIES, INC.
925 West 1800 South Logan, Utah 84321

TELEPHONE
435.792.8000

FAX
435.792.8001

E-MAIL

WEB ADDRESS
http://www.hyclone.com/

EMPLOYEES
US: 660
Elsewhere: 252

FOUNDED
1967

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Launches Human Safety Study of Ebola Vaccine Candidate
August 29, 2014
Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
USP Awards Analytical Research
August 15, 2014
Author Guidelines
Source: BioPharm International,
Click here